From Fragmentation to Intelligence: Global Healthcare Supply Chain Leaders Share Their Vision for the Future
An Interview Feature with the ISCEA / IMPA Healthcare Advisory Board
Healthcare supply chains have rapidly evolved from operational back-office functions into critical enablers of patient outcomes, system resilience, and global health equity. As disruption becomes constant—driven by geopolitical instability, pandemics, and technological acceleration—health systems must rethink how they design, manage, and govern supply networks.
In this exclusive interview feature, members of the ISCEA / IMPA Healthcare Advisory Board share their perspectives on the trends, technologies, and leadership strategies shaping the future of healthcare supply chains.
Kevin Lewis discusses the shift toward value-based supply chains, emphasizing patient safety, transparency, and strategic decision-making in healthcare systems.
How can healthcare systems better prepare for disruption while improving resilience and continuity of care?
Supply chain disruption must be treated as a patient safety issue, not a purchasing problem. This requires identifying critical products, validating substitutions, and improving regional coordination.
What role should AI and data visibility play in modern healthcare supply chains?
In an AI-driven environment, poor data does not create better outcomes—it creates faster mistakes. Real-time visibility is essential for protecting patients and enabling informed decisions.
How must procurement evolve from cost-focused to value-based decision-making?
A 360-degree value analysis is essential, incorporating patient safety, clinician efficiency, resilience, and total system impact.
What skills will define the next generation of healthcare supply chain leaders?
Systems thinking, data literacy, and cross-functional collaboration will be essential, along with rapid decision-making during disruption.
What is one bold prediction for the future of healthcare supply chains?
The next decade will bring a fundamental shift toward executive-level transparency and accountability in healthcare supply chains. As scrutiny increases, organizations will be required to disclose conflicts of interest, strengthen governance structures, and implement independent data oversight. This transformation will redefine trust in healthcare systems. Those that embrace transparency will be viewed as safer and more resilient, while those that resist will face regulatory pressure, reputational risk, and potential harm to patient outcomes.
